The investigative business journalism Web site ShareSleuth has posted its second story since it started this summer, and once again majority owner Mark Cuban has shorted stock in the company that the piece focuses on.
The piece is about UTEK Corp., a Florida-based technology transfer company, and the article states, “Cuban also has sold short 75,000 shares of UTEK’s stock at an average price of around $20 a share. Christopher Carey, editor of Sharesleuth.com, does not invest in individual stocks and has no position in the shares of Xethanol or UTEK.” UTEK’s shares closed on Wednesday, Oct. 25, at $19.01. The last time the shares traded at $20 was on Oct. 2, meaning that Cuban invested in the stock at least three weeks before the article was published.
As far as the journalism involved, this article is an exhaustive piece of research that discloses some shady practices by this company and its business partners. Read more here.
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…
Members of the CoinDesk editorial team have sent a letter to the CEO of its…
The Capitol Forum is seeking a detail-oriented and collaborative Deputy Managing Editor to support the…
View Comments
The Mark Cuban-backed sharesleuth.com blog seems to be doing a fine job lining his pockets at the expense of honest shareholders. Unfortunately, it appears alarmingly easy in this day and age to pump-down the value of one's short position by hiring a blogger to tenuously string together a questionable "story" and conclude guilt by association. Cuban's use of scare tactics to sway honest shareholders while attempting to sabotage the value creation of a promising technology transfer company like Utek should be a matter of concern to all. Morningstar's Stock Grades on 11/03/06 for Utek are A+, B and C+. Why the disparity between Morningstar's research and Cuban's pseudo-investigative reporting? Seems Cuban and his blog-writer have a conflict of interest.